Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026)

Revvity's (RVTY) quarterly Other Non-Current Liabilities came in at $771.4 million in Q3 2026, up 3557.46% on a YoY basis from $21.1 million in Q3 2025, and up 2984.08% quarter-over-quarter from $25.0 million in Q2 2026.

Analysis

Revvity (RVTY) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Revvity (RVTY) has reported Other Non-Current Liabilities for 17 consecutive years, with $771.4 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Other Non-Current Liabilities rose 3557.46% year-over-year to $771.4 million; the trailing twelve-month figure through Jul 2026 stood at $771.4 million (up 3557.46% YoY), and the FY2025 full-year result was $807.5 million, up 3611.95% from the prior year.
  • Other Non-Current Liabilities grew to $771.4 million in Q3 2026 per RVTY's latest filing, from $25.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.2 billion in Q4 2022 and bottomed at $19.7 million in Q1 2025.
  • Historically, Other Non-Current Liabilities has averaged $309.4 million across 5 years, with a median of $46.6 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 45.62% in 2024, then soared 3611.95% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $1.2 billion in 2022, then slumped by 96.75% to $40.0 million in 2023, then plunged by 45.62% to $21.8 million in 2024, then jumped by 3611.95% to $807.5 million in 2025, then fell by 4.47% to $771.4 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $771.4 million, $25.0 million, and $807.5 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 771.36 Mn
Apr 5, 2026 25.01 Mn
Dec 28, 2025 807.46 Mn
Sep 28, 2025 755.16 Mn
Jun 29, 2025 21.09 Mn
Mar 30, 2025 19.74 Mn
Dec 29, 2024 21.75 Mn
Sep 29, 2024 846.00 Mn
Jun 30, 2024 30.54 Mn
Mar 31, 2024 30.52 Mn
Dec 31, 2023 40.01 Mn
Oct 1, 2023 993.05 Mn
Jul 2, 2023 37.56 Mn
Apr 2, 2023 43.83 Mn
Jan 1, 2023 46.62 Mn
Oct 2, 2022 1.23 Bn
Jul 3, 2022 48.59 Mn
Apr 3, 2022 49.83 Mn
Jan 2, 2022 58.00 Mn
Oct 3, 2021 1.51 Bn